Kuala Lumpur: Scorpius Holdings Inc, a United States-based integrated contract development and manufacturing organisation, is exploring the establishment of a halal-compliant biomanufacturing facility in Malaysia as part of its international expansion strategy.

According to BERNAMA News Agency, the company has initiated discussions with key Malaysian stakeholders and regulatory authorities to potentially set up a local subsidiary. This initiative is aimed at serving the regional and global demand for halal-certified biopharmaceutical products, addressing a significant gap in access to halal-certified biologics for the global Muslim population.

Jeff Wolf, Chief Executive Officer of Scorpius Holdings, stated that the move is part of the company’s broader strategic restructuring to improve operational efficiency and drive long-term growth. The restructuring includes a 28 percent reduction in headcount and the consolidation of operations by closing its North Carolina facilities, which is expected to result in over US$6 million in annualised cost savings.

Meanwhile, Science, Technology and Innovation Minister Chang Lih Kang welcomed the initiative, highlighting its alignment with Malaysia’s ambition to become a global hub for halal biopharmaceutical innovation. To support this global push, Scorpius has appointed prominent Malaysian entrepreneur Tan Sze Thuan to its Board of Directors, whose expertise in Southeast Asia’s logistics and regulatory environment is anticipated to aid in the company’s regional expansion efforts.

Scorpius Holdings continues to offer biologics manufacturing, process development, and analytical services to global clients while pursuing strategic alternatives to enhance shareholder value.